We focus on
KEEPING YOU UPDATED

Mar 30 2021

SERB acquires Veriton Pharma

SERB expands presence in UK specialty pharmaceuticals and strengthens its neurology and rare disease franchise with the acquisition of Veriton Pharma.

Veriton Pharma, a private pharmaceutical company specialising in the development of licensed and unlicensed medicines for patients with neurological conditions and rare metabolic diseases.